Risk factors and clinical presentations of long COVID in Africa: A scoping review.


Journal

Journal of infection and public health
ISSN: 1876-035X
Titre abrégé: J Infect Public Health
Pays: England
ID NLM: 101487384

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 12 02 2023
revised: 18 09 2023
accepted: 20 09 2023
medline: 27 11 2023
pubmed: 28 10 2023
entrez: 27 10 2023
Statut: ppublish

Résumé

COVID-19-related complications can last for years, even in patients who are asymptomatic during the acute phase, a phenomenon referred to as long COVID. This scoping review aimed to summarize the risk factors and clinical symptoms of long COVID in Africa between 2020 and 2022. Five studies were included. Three of the studies used in this review were retrospective cross-sectional studies, one was a prospective cohort study while another one was a case-control study. The review identified several risk factors for long COVID, including being female, being older than 40 years, having more than four acute COVID-19 symptoms, and having concomitant conditions such as asthma, hypertension, and depression. General, respiratory, cardiovascular, otolaryngological, gastrointestinal, and neurological symptoms were among the reported long COVID symptoms. To ensure that patients with long COVID are diagnosed and treated early, the risk factors and clinical symptoms of long COVID need to be identified for different population groups.

Identifiants

pubmed: 37890221
pii: S1876-0341(23)00317-9
doi: 10.1016/j.jiph.2023.09.021
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1982-1988

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Enos Moyo (E)

Medical Center Oshakati, Oshakati, Namibia.

Munashe Chimene (M)

Africa University, Mutare, Zimbabwe.

Perseverance Moyo (P)

Medical Center Oshakati, Oshakati, Namibia.

Godfrey Musuka (G)

International Initiative for Impact Evaluation, Harare, Zimbabwe.

Derek Mangoya (D)

The Centre for HIV and AIDS Prevention Studies, Windhoek, Namibia.

Grant Murewanhema (G)

University of Zimbabwe, Harare, Zimbabwe.

Tafadzwa Dzinamarira (T)

School of Health Systems and Public Health, Pretoria, South Africa. Electronic address: u19395419@up.ac.za.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH